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A B S T R A C T   
The presence of some species of helminths is associated with changes in host microbiota composition and di-
versity, which varies widely depending on the infecting helminth species and other factors. We conducted a 
prospective case-control study to evaluate the gut microbiota in children with Opisthorchis felineus infection 
(n=50) before and after anthelmintic treatment and in uninfected children (n=49) in the endemic region. A total 
of 99 children and adolescents aged between 7 and 18 years were enrolled to the study. Helminth infection was 
assessed before and at 3 months after treatment with praziquantel. A complex examination for each participant 
was performed in the study, including an assessment of the clinical symptoms and an intestinal microbiota survey 
by 16S rRNA gene sequencing of stool samples. There was no change in alpha diversity between O. felineus- 
infected and control groups. We found significant changes in the abundances of bacterial taxa at different 
taxonomic levels between the infected and uninfected individuals. Enterobacteriaceae family was more abundant 
in infected participants compared to uninfected children. On the genus level, O. felineus-infected participants’ 
microbiota showed higher levels of Lachnospira, Escherichia-Shigella, Bacteroides, Eubacterium eligens group, 
Ruminiclostridium 6, Barnesiella, Oscillibacter, Faecalitalea and Anaerosporobacter and reduction of Blautia, Lach-
nospiraceae FCS020 and Eubacterium hallii group in comparison with the uninfected individuals. Following 
praziquantel therapy, there were significant differences in abundances of some microorganisms, including an 
increase of Faecalibacterium and decrease of Megasphaera, Roseburia. Enterobacteriaceae and Escherichia abun-
dances were decreased up to the control group values. Our results highlight the importance of the host-parasite- 
microbiota interactions for the community health in the endemic regions.   
1. Introduction 
There is an increase in the prevalence of chronic, non-communicable 
diseases, including allergic and autoimmune diseases in developed 
countries (Burisch et al., 2014; Lai et al., 2009). According to the “old 
friends hypothesis”, insufficient infectious stimulation and decrease of 
helminthiasis prevalence are associated with chronic inflammatory 
disease development (Cooper et al., 2003; Wendel-Haga and Celius, 
2017; Yazdanbakhsh et al., 2001). Helminth infection can also be 
detrimental in reducing vaccine responses, increasing susceptibility to 
coinfection and potentially reducing tumor immunosurveillance (Mai-
zels and McSorley, 2016). Helminths establish long-term chronic in-
fections associated with the suppression of the host immune response 
(Maizels et al., 2018; Ramanan et al., 2016; Wammes et al., 2016). This 
effect potentiates their long-term survival within their host, but can 
additionally affect the immune response to other infections and foreign 
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antigens (Hsieh et al., 2014; Reynolds et al., 2017; Su et al., 2018). 
Multiple mechanisms contribute to the modulation of host immunity 
during helminth infection (Maizels et al., 2018). It is suggested that the 
impact on composition and function of the intestinal microbiome is one 
of the mechanisms by which helminths affect host immunity (Reynolds 
et al., 2014; Walk et al., 2010). Altered microbial composition is asso-
ciated with allergic diseases, inflammatory bowel diseases, cancer and 
autoimmune diseases (Imhann et al., 2018; Repass et al., 2016; Tyakht 
et al., 2018; Wendel-Haga and Celius, 2017). 
The study of the relationship between helminth infection and gut 
microbiota is becoming more important because they both contribute to 
the modulation of the immune system in various inflammatory diseases 
(Schachter et al., 2020; Zaiss et al., 2015). However, findings of previous 
studies of the effect of helminths on the microbiome are inconsistent and 
depend on the type, duration and intensity of helminth infection (Rosa 
et al., 2018; Xu et al., 2018). Previous study showed that the presence of 
Opisthorchis viverrini infection changed the composition of the gut and 
bile microbiome in experimental animals (Plieskatt et al., 2013). Sup-
posedly, liver flukes and helminth-modified microbiota together lead to 
chronic inflammation that promotes the fibrosis and malignancies 
(Chng et al., 2016; Sripa et al., 2012). 
The liver fluke Opisthorchis felineus is endemic in Europe and in large 
parts of the Russian Federation, particularly in Siberia, where the 
prevalence may exceed 50% in adults (Fedorova et al., 2018). The 
infection occurs through the consumption of raw or undercooked cyp-
rinoid fish. Chronic O. felineus infection may lead to several severe liver 
and bile duct diseases, such as cholecystitis, cholangitis and periductal 
fibrosis and might increase the risk for cholangiocarcinoma (Gouveia 
et al., 2017). Recent studies indicate that a chronic O. felineus infection 
modifies the immune reactivity by increasing of the synthesis of sup-
pressors of the immune response IL10 and TGF-β and reducing the level 
of proinflammatory markers IL-4, IL-5, and might have a protective ef-
fect against allergies (Fedorova et al., 2017). 
There is increasing evidence that helminth-induced changes in gut 
microbial composition affect the host immune response (Gause and 
Maizels, 2016; Zaiss et al., 2015). In this regard, it is important to study 
the mutual influence of the intestinal microbiota and helminth in-
fections on the development of chronic non-communicable diseases. The 
aim of this study was to identify potential interactions between 
O. felineus infection, praziquantel treatment and intestinal microbiota. 
2. Materials and methods 
2.1. Ethics statement 
Study procedures were followed in accordance with the ethical 
standards of the Helsinki Declaration of the World Medical Association. 
The study protocol was approved by the Ethical Committee of Siberian 
State Medical University (SibMed), Tomsk (N 4981, 24.10.2016). 
Written informed consents were obtained from adolescents 15 years and 
older, and parental consents were obtained for children under 15 years 
old. 
2.2. Study design and sampling 
A prospective case-control study was conducted in Tomsk Region 
(Western Siberia, Russian Federation) between November 1, 2016 and 
June 30, 2018. We recruited two groups of children aged 7-18 years 
consisting of subjects infected with the helminth O. felineus (n=50) and 
uninfected by O. felineus and other helminths (n=50) (Fig.S1 in the 
supplemental material). The recruitment of the infected patients was 
conducted at the Regional Children’s Hospital, uninfected controls were 
enrolled in the Center of Health for Children. Prior to the study, all 
subjects were asked to collect two stool samples collected on two 
consecutive days. Patients with O. felineus infection received standard 
treatment by praziquantel with a dose of 60 mg/kg body weight divided 
into three doses (at intervals of 4 hours) for one day. Follow-up period 
after the treatment was 3 months and included the assessment of clinical 
symptoms and efficacy of anthelmintic treatment via microscopy of 
stool samples. 
Inclusion criteria for patients with O. felineus infection were partic-
ipants who provided two stool samples for examination (microscopy) 
and at least one stool sample positive for the O. felineus infection. In-
clusion criteria for uninfected controls and patients after treatment 
were: two stool sample negative for the O. felineus infection and other 
helminthic/protozoa infections. Exclusion criteria for patients with 
O. felineus infection, patients after treatment and uninfected children 
were: anthelmintic and/or antimicrobial treatment 3 months prior to the 
study, probiotic treatment within the 4 weeks prior to the start of the 
study, were co-infection with other helminths/protozoa and/or had 
comorbidities, less than 5,000 reads per sample according to 
sequencing. In total, 50 infected and 49 uninfected children and ado-
lescents were enrolled and completed assessments (two stool samples, 
completed examination, sequencing results); of those, 48 infected pa-
tients finished follow-up period after the treatment. Samples from two 
subjects, those collected after treatment, were taken out of the analysis. 
2.2.1. Interviews and physical examination 
Study participants were interviewed using a pre-tested questionnaire 
(Zvonareva et al., 2018). Data collected was about demographic status 
(age, gender), risk factors for O. felineus infection (habitual practices of 
raw fish consumption, personal hygiene) and comorbidities. Study 
participants passed clinical examination by a physician. We assessed 
complaints, skin, respiratory, cardiovascular, digestive and hep-
atobiliary systems, height and weight. Particular attention was paid to 
symptoms associated with O. felineus infection: pain in right subcostal 
area, nausea, skin rash before and after treatment. The biochemical tests 
of the blood serum samples were carried out using DiaSys Diagnostic 
Systems GmbH kits (Table S1). The following indicators were measured: 
total protein, glucose, bilirubin total, the bound fraction bilirubin, 
enzymatic activity of alanine aminotransferase, aspartate aminotrans-
ferase, gamma-glutamyltransferase, and alkaline phosphatase. Ultraso-
nography of the liver and bile ducts was performed by a mobile, high 
resolution ultrasound device (Shenzhen Mindray Bio-Medical Elec-
tronics, Co, Ltd). 
2.2.2. Stool examination and sample storage 
Prior to the study, all subjects were asked to collect two stool samples 
on two consecutive days. The participants were provided with sterile 
plastic containers to store the samples. The stool samples were trans-
ported in cooled containers (4◦C) no more than one hour to the labo-
ratory. We used PARASEP (DiaSys Ltd, UK) for the examination of the 
parasite eggs. The microscopy analysis for the presence of intestinal 
parasites/eggs was carried out in the diagnostic laboratory of SibMed by 
a certified specialist on the day of sampling. The number of eggs per 
gram (EPG) of feces was recorded for O. felineus and the infection in-
tensity was calculated. The intensity O. felineus infection was grouped in 
low (0-999 EPG), moderate (1000-9999 EPG), and severe intensities 
(10,000 and above EPG) (Elkins et al., 1991). Three months 
post-treatment the microscopy were carried out using the same pro-
cedure as described above. 
For the DNA extraction, there were stool samples collected from 50 
uninfected children and from patients with O. felineus infection before 
(n=50) and 3 months after treatment (n=48). All post-treatment sam-
ples sequenced for this study were helminth-negative by microscopy. 
The collected stool samples were frozen and stored at -80◦С at the 
"Biobank Sibmed” department until used for DNA extraction. DNA from 
all stool samples was isolated less than 2 months following collection. 
2.3. DNA extraction and sequencing of 16S rRNA gene 
The DNA samples were isolated from each sample (150 mg) by using 
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FastDNA SPIN Kit for Soil (MP Biomedicals, USA) and according to the 
manufacturer’s recommendations. The DNA samples were diluted 500 
times. DNase and pyrogen free water (DES) from the FastDNA SPIN Kit 
for Soil was used for dilution of the purified DNA. Isolated DNA was 
stored at -80◦C. Blank extractions were included as negative controls to 
monitor for bacterial contamination. The V4 hypervariable region of the 
16S rRNA gene was amplified by PCR in 1 round using a modification of 
F515 and R806 barcoded primers (GTGBCAGCMGCCGCGGTAA and 
GACTACNVGGGTMTCTAATCC, respectively) with the double-index 
sample barcoding primer system described in (Fadrosh et al., 2014). 
Amplification was performed using C1000 Touch Thermal Cycler 
(Bio-Rad, USA) under the following cycling conditions: initial denatur-
ation 60 s at 98◦C, followed by 30 cycles of 15 s at 98◦C, 15 s at 58◦C and 
25 s at 72◦C, final extension of 5 min at 72◦C. Purification of the PCR 
products was performed using the Cleanup Mini kit for the extraction of 
DNA for reagent mixtures (Evrogen, Russia). The concentration of the 
obtained 16S rRNA gene libraries in the solution was measured with 
Qubit fluorometer (Invitrogen, USA) using Quant-iT dsDNA 
High-Sensitivity Assay Kit. The purified amplicons were mixed equi-
molarly in accordance with the assessed concentrations. The quality of 
the library prepared for sequencing was assessed using the electropho-
resis in 2% agarose gel. The final concentration of the pooled library 
prepared for sequencing on MiSeq platform was 12.5 pM (measured 
with Qubit fluorometer as described above for the individual libraries). 
Sequencing of the pooled library was performed using MiSeq Re-
agent Kit v2 (2*250 cycles) on MiSeq sequencer (Illumina, USA) 
following the manufacturer’s instructions. Each sample was sequenced 
in duplicate to even the depth of coverage. In addition to patient sam-
ples, the sequencing of isolation, amplification and sequencing of con-
trol samples also was carried out. 
2.4. Bioinformatic analysis 
The pooled reads were demultiplexed using deML (Renaud et al., 
2015). After the quality trimming, the concatenation of the paired reads 
was performed using SeqPrep tool. Prior the analysis, the replicates were 
concatenated into one FASTQ file. Sequence processing and diversity 
analyses were performed with QIIME 2 version 2019.1.0 (Bolyen et al., 
2019). 
After being imported into the QIIME 2 artifact, all sequences were 
quality-checked in sliding window via quality-filter q-score-joined 
script, filtered with a threshold of Phred score = 30 and then der-
eplicated. For chimeric reads identification and removing, a de novo 
approach was used with vsearch uchime-denovo script. Closed-reference 
clustering strategy was used for operational taxonomic units (OTUs) 
selection with 99% similarity SILVA 132 release (Yilmaz et al., 2014) as 
a reference database and q2-vsearch as picking algorithm. OTUs taxo-
nomic classification was performed using q2-feature-classifier plugin 
with naive Bayes classifier trained on 515F/806R region of 16S rRNA 
gene sequences from SILVA database. Technical control samples were 
manually checked and the reads identified as contaminants were sub-
tracted from the microbiome samples. Samples containing less than 
5000 reads were excluded from further analysis. 
Prior to the taxonomic richness and α-diversity computation, the 
samples were rarefied to the depth of 5000 classified reads. Faith index, 
Shannon index, and the number of observed OTUs were calculated for 
each of the samples at the level of OTUs. The DEICODE plugin of QIIME 
2 with default parameters was used to calculate pairwise samples 
dissimilarity (β-diversity)(Martino et al., 2019). Beta-diversity was 
calculated for all samples and separately for the group of 
O. felineus-infected before and after treatment, and uninfected 
individuals. 
2.5. Statistical analysis 
Statistical analysis was conducted in R language, version 3.6.1(R 
Core Team, 2019). Differences in measured clinical symptoms, 
biochemical and ultrasonography parameters of O. felineus-infected and 
uninfected individuals were assessed with Mann-Whitney-Wilcoxon test 
(for quantitative variables) and with chi-square test (for qualitative 
variables). 
The three-groups (O. felineus-infected, after treatment, and unin-
fected) alpha-diversity comparison was implemented using a linear 
mixed model with O. felineus infection status as a fixed effect and pa-
tient’s identifier as a random effect (Bates et al., 2015). For post hoc 
analysis, the difflsmeans function of lmerTest package was used (Kuz-
netsova et al., 2017). Associations between infection intensity and 
alpha-diversity indices were examined with negative binomial regres-
sion on O. felineus infected group (Venables and Ripley, 2002). The 
O. felineus EPG counts value was used as a dependent variable. 
Beta-diversity analysis was performed for all samples and the groups 
of infected patients and uninfected controls. On whole sample, pairwise 
permutational analysis of variance (PERMANOVA) for distance matrices 
with 9999 permutations was performed on all samples to check the 
separation between O. felineus-infected, after treatment, and uninfected 
(R Core Team, 2019). For the O. felineus-infected and uninfected in-
dividuals, the impact of different clinical factors, including complaints, 
biochemistry, results of physical and ultrasound examination along with 
helminthic infection was tested in multivariate adonis model (Oksanen 
et al., 2019). 
Prior to the statistical analysis of taxa abundance, OTU table was 
exported to R with import_biom function, rarefied to the depth of 5000 
reads per sample and aggregated on the levels of phyla, families, genera, 
and species with tax_glom function (McMurdie and Holmes, 2013). All 
phylogenetic levels were inspected separately. 
-Analyses of taxa abundance were performed using a generalized 
linear mixed model with negative binomial distribution for taxa abun-
dance (Brooks et al., 2017). Infection status was selected as a fixed effect 
and patient’s identifier as a random effect. All models were checked with 
II-type ANOVA (Therneau, n.d.); for the significant models, the esti-
mated marginal means were calculated in each group, and Tukey post 
hoc analysis was performed (Lenth, 2019). Associations of infection in-
tensity and microbial phylotypes abundance were identified similarly to 
α-diversity. 
In case of multiple hypotheses testing, the p-values were adjusted 
with FDR method and referred as q-values. Visualization was performed 
with ggplot2 package (Wickham, 2006). Additional exploratory analysis 
of the microbiome data was performed using Knomics-Biota platform 
(Efimova et al., 2018) 
3. Results 
3.1. Characteristics of the study cohort 
The study groups included 99 children (50 patients with O. felineus 
infection and 49 uninfected subjects). Two samples collected at post- 
treatment were excluded: one subject used antibiotics, another one 
refused to perform stool sample collection. 
Participants’ age ranged from 7 to 18 years old, with a median age of 
11 (8-14) for O. felineus infected patients and 10 (8-13) for the control 
group. Age and gender distribution were similar between the two 
groups. Table 1 summarizes the participants’ characteristics: clinical 
symptoms, biochemical tests, abdominal ultrasound. Among the most 
common complaint in O. felineus infected patients was pain in abdomen 
(q<0.01), in particular, pain in the right subcostal area. According to the 
results of the biochemical test of the blood serum, the level of glucose 
and the activities of alkaline phosphatase, alanine aminotransferase, and 
gamma-glutamyltransferase were significantly higher in O. felineus 
infected participants than in uninfected ones. The levels of protein, total 
and conjugated bilirubin were statistically significantly lower in infected 
patients (Table 1). After anthelmintic treatment, the frequency of 
abdominal pain (94% vs 40%, q<0.01) and other clinical symptoms 
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tended to decrease (Table S2). 
According to results of the ultrasound examination, we found a trend 
towards gallbladder length increase and wall thickening in infected 
subjects; however, these differences were not statistically significant 
(Table 1). 
Infection intensity varied between 2 and 3800 eggs/gram, and the 
mean rate count was 363±1004 EPG of feces, with 92.8% of participants 
having low intensity infection (2-500 EPG). 
3.2. Sequencing results 
There were 153 samples (148 fecal samples and 5 technical blank 
controls) prepared for sequencing. The Illumina sequencing produced 
3,736,220 reads in total. Quality check and chimeric reads exclusion 
resulted in 3,549,659 reads retained. After filtering of contaminant se-
quences according to negative controls, there were 3,300,456 reads left 
for which 13,415 OTUs were identified. One sample in the uninfected 
group was excluded from further analysis due to low coverage (less than 
5,000 reads per sample). A total of 147 samples were included in the 
further analysis. The number of reads per sample was 21,576 [16,621; 
25,594] (Median [Q2; Q4]). 
3.3. Microbial diversity, helminthic infection and treatment 
Taxonomic richness and α-diversity of subjects’ gut microbiota was 
calculated using Faith and Shannon indices as well as the number of 
observed OTUs at a depth of 5000 sequences per sample. There were no 
differences in α-diversity between O. felineus-infected, uninfected, and 
treated patients for any of these indices (Fig. 1A to C; Table S3; Fig. S2). 
However, we identified significant positive correlation between infec-
tion intensity pretreatment and richness and α-diversity for each of the 3 
metrics (Fig. 1D to F). One patient with an outlying infection intensity of 
3800 EPG of feces was excluded only from the EPG and bacterial 
abundance associations testing for the purpose to control false positives 
associations. 
PERMANOVA applied to all samples showed separation between 
O. felineus-infected and uninfected microbiomes (R2=0.053, p=0.006), 
as well as between O. felineus-infected and treated groups (R2=0.072, 
p=0.002) (Fig. 2). There was no significant differences in gut microbiota 
between samples collected from infected children before and after 
anthelmintic treatment (R2=0.018, p=0.168). Significant associations 
were observed for O. felineus infection (R2=0.065, p=0.002), age 
(R2=0.038, p=0.017), and skin rash presence (R2=0.033, p=0.028) 
(Table S4). 
3.4. Gut microbiota composition and O. felineus infection 
On the level of phyla, patients with O. felineus infection had depletion 
in Firmicutes and increase of Proteobacteria abundance in gut micro-
biome compared to healthy controls (Table 2). 
On the family level, O. felineus infection was linked to an increase of 
Enterobacteriaceae in the gut microbiota of children (Table 2). 
Among the genera positively associated with the liver fluke infection, 
we identified Lachnospira, Escherichia-Shigella, Bacteroides, Eubacterium 
eligens group, Ruminiclostridium 6, Barnesiella, Oscillibacter, Faecalitalea, 
and Anaerosporobacter. Healthy volunteers showed higher levels of 
Blautia, Lachnospiraceae FCS020 group and Eubacterium hallii group in 
comparison with the infected individuals (Table 2).The observations 
were generally consistent with the results of a complementary pipeline 
available online as interactive reports at https://biota.knomics.ru/ 
opisthorchis-and-gut-microbiome-2019. 
3.5. Infection intensity and gut microbiota 
For the O. felineus-infected patients, negative binomial regression 
was performed to identify associations between the infection intensity 
and the levels of microbial taxa. On the level of phyla, positive associ-
ations were identified for Firmicutes and Tenericutes, and negative as-
sociations were identified for Verrucomicrobia and Proteobacteria (Fig. 
S3A). On the family level, Desulfovibrionaceae and Erysipelotrichaceae 
showed direct associations with infection intensity, and inverse corre-
lations were found for Bifidobacteriaceae (Fig. S3B). Among the genera 
positively associated with the infection intensity we identified Cat-
enibacterium, Desulfovibrio, Mitsuokella, Ruminococcaceae UCG-003, 
Enterorhabdus, Howardella, Olsenella, Moryella, Rikenellaceae RC9 gut 
group, Candidatus Soleaferrea, Senegalimassilia, Eubacterium copro-
stanoligenes group. Erysipelatoclostridium, Anaerostipes, Bifidobacterium, 
Eubacterium hallii group, Ruminococcus gnavus group, Gordonibacter and 
Akkermansia abundances demonstrated negative associations with the 
number of O. felineus EPG of faeces (Fig. S3C). 
3.6. Liver fluke treatment affects gut microbiota structure 
After anthelmintic treatment Firmicutes abundance was increased 
whereas Proteobacteria level was decreased to the uninfected partici-
pants’ proportions (Table 2). Enterobacteriaceae content also was 
decreased to the levels observed in uninfected children. Drug adminis-
tration led to a decrease of Synergistetes and Atopobiaceae levels 
compared with O. felineus-infected and control groups (Table 2). 
Atthe genus level, in gut microbiota of praziquantel-treated patients 
we identified the reduction of Lachnospira, Ruminiclostridium 6, 
Table 1 








Male, %* 42.86 30 0.401 
Female, %* 57.14 70 0.401 
Years** 10 (8;13) 11 (8.25;13.75) 0.463 





Clinical symptoms, %* 
Abdominal pain 22.45 94 <0.001 
Pain in right subcostal 
area 
12.24 56 <0.001 
Abdominal pain in 
other sites 
14.29 82 <0.001 
Nausea 32.65 52 0.141 
Pyrosis 14.29 8 0.590 
Diarrhea 14.29 6 0.435 
Constipation 22.45 22 0.956 
Weakness 34.69 18 0.158 
Skin rash 18.37 24 0.715 
Biochemistry** 
Protein, g/L 76 (72.75;78) 73 (70;75.925) 0.011 
Glucose, mmol/L 4.05 (3.6;4.6) 4.55 (4.4;4.7) 2.00E-004 
Bilirubin total, μmol/L 14.65 (11.73;16.8) 9.35 (6.85;13.95) <0.001 
Bilirubin conjugated, 
μmol/L 








19 (14.25;24) 22.5 (18;27) 0.054 
Gamma glutamyl 
transferase, U/L 
14 (11;16) 17.5 (15;21) <0.001 
Alkaline phosphatase, 
U/L 




Gallbladder wall thickened, %* 14.29 20 0.708 





Gallbladder length, mm ** 59 (55;66) 65 (60;72.75) 0.055 
* - Chi-square test 
** Median (Q1;Q3), Mann-Whitney-Wilcoxon test 
P < 0.05 indicates significant different. 
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Anaerosporobacter and Escherichia-Shigella abundances along with in-
crease in Blautia, Eubacterium hallii group and Lachnospiraceae FCS020 
group levels up to the control group values (Table 2). Additionally, we 
observed the depletion of Roseburia, Megasphaera levels and expansion 
of Faecalibacterium, Eisenbergiella, Sellimonas, Olsenella, Varibaculum, 
Rikenellaceae RC9 gut group, Erysipelatoclostridium in gut microbiota 
after treatment compared with O. felineus-infected and control groups. 
Flavonifractor and Leuconostoc had higher proportions in gut microbiota 
after treatment compared with controls (Table 2). In addition, prazi-
quantel treatment results in reduction of Ruminococcus gauvreauii group, 
Howardella and Slackia abundances in gut microbiome compared with 
controls and, for Lachnospiraceae NK4A136 group and ND3007 group, 
Tyzzerella 4, Prevotella 2, in comparison with O. felineus-infected patients 
(Table 2). Praziquantel-treatment did not reduce levels of Bacteroides, 
Oscillibacter, Faecalitalea, Eubacterium eligens group and Barnesiella 
augmented in the gut microbiota of O. felineus-infected individuals 
(Table 2). 
4. Discussion 
In this study, we described for the first time the changes in the gut 
microbiota of O. felineus-infected children before and after anthelmintic 
treatment based on oral praziquantel application in an endemic rural 
area. Neither the presence of O. felineus infection nor the praziquantel 
treatment were associated with differences in the alpha-diversity, rich-
ness, or clinical symptoms compared with the control group. In other 
studies the analysis of the microbiota by high-throughput sequencing 
revealed that infection with the liver flukes O. viverrini and C. sinensis 
lead to increases in alpha-diversity in microbial communities in the 
colon (Plieskatt et al., 2013; Xu et al., 2018). Analysis of the composition 
of the bile microbiota in the presence of O. felineus infection was carried 
out in two studies (in experimental animals and patients with choleli-
thiasis) using the sequencing of the 16S rRNA gene (Saltykova et al., 
2016, 2017). In an experimental study, the O. felineus infection was 
associated with increased bacterial diversity in the bile ducts as assessed 
by the Chao index (Saltykova et al., 2017). The study of patients with 
cholelithiasis showed that the presence of O. felineus infection did not 
Fig. 1. Alpha diversity plots. 
On the figure, plots A, B, and C represents Faith 
and Shannon diversity indices along with the 
number of observed OTUs respectively 
measured for gut microbiota of studied cohort. 
Boxes represent the interquartile range (IQR) 
between the first and third quartiles, and the 
line inside represents the median. Whiskers 
denote the lowest and the highest values within 
1.5 IQR from the first and third quartiles, 
respectively. Individual points represent out-
liers beyond the whiskers. Plots D, E, and F 
represents associations between infection in-
tensity measured as the number of O. felineus 
eggs per gram of feces and the Faith index, 
Shannon index and the number of observed 
OTUs for infected children.   
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lead to increased diversity of bile microbiota (Saltykova et al., 2016). 
However, we found significant positive associations between the 
O. felineus infection intensity and gut community structure in children. 
We did not detect increased alpha-diversity of the microbiota, probably 
due to the low intensity of invasion in the study group. Additionally, the 
O. felineus infection is endemic and hence may have already left its 
imprint on the gut microbiota composition of all individuals in the study 
region (Easton et al., 2019). 
Many microbial taxa were differentially abundant between the 
infected and non-infected individuals. In the main, significant micro-
biota changes were observed within the Firmicutes phylum, including 
the Clostridales order. This result was consistent with some previous 
studies of the gut microbiota in subjects infected by soil-transmitted 
helminths. (Cooper et al., 2013; Rosa et al., 2018). 
Our data revealed that O. felineus infection is associated with an in-
crease in the relative abundance of pro-inflammatory Proteobacteria, 
mainly Enterobacteriaceae, and a decrease in the relative abundance of 
commensal Firmicutes (Blautia, Eubacterium hallii group, Lachnospir-
aceae FCS020 group). At the same time, at the genus level we observed 
an increase in the abundance of some bacteria from the Firmicutes 
compared with the control group. In contrast, a positive correlation was 
identified for Firmicutes and a negative association was found for Pro-
teobacteria with the infection intensity. The decrease in Firmicutes and 
an increase in Proteobacteria taxa is one of the signatures of the mi-
crobial dysbiosis in inflammatory bowel diseases (IBD) (Gophna et al., 
2006). Enterobacteriaceae, including Escherichia, were also increased in 
O. felineus infected samples. This family is associated with the liver fluke 
O. viverrini infection in hamsters (Plieskatt et al., 2013). 
Helminth-induced changes in gut microbial diversity can participate in 
the development of hepatobiliary diseases (Carpenter, 1998; Itthitae-
trakool et al., 2016; Sanduzzi Zamparelli et al., 2017; Scholte et al., 
2018). A number of studies demonstrated that patients with liver 
cirrhosis and primary biliary cholangitis showed a significant increase in 
the abundance of the Enterobacteriaceae family compared with the 
healthy group (Liu et al., 2012; Lu et al., 2011). There is growing evi-
dence that the numbers of the Enterobacteriaceae are linked to IBD 
(Nishida et al., 2018; Swidsinski et al., 2002; Tyakht et al., 2018; Varela 
et al., 2013). A number of studies have shown that patients with celiac 
disease, ulcerative colitis, and Crohn’s disease have an increased pro-
portion of E. coli in the gut microbiota compared to healthy individuals 
(Collado et al., 2009; Mondot et al., 2011; Nadal et al., 2007; Swidsinski 
et al., 2002). 
Сompared to healthy participants, O. felineus-infected patients 
manifested a significant decrease of Blautia, Eubacterium hallii group, 
and an increase of Lachnospira abundances, that may produce anti- 
inflammatory short-chain fatty acids (SCFAs) (Park et al., 2015, 
2012). One of the potential biomarkers of a healthy gut often considered 
in microbiome surveys is the relative abundance of butyrate-producing 
microbes (Chang et al., 2014; Machiels et al., 2014). Bacteria that 
ferment dietary fibers to produce SCFAs are typically reduced in mucosa 
and feces of patients with IBD, as compared to healthy individuals 
(Kumari et al., 2013; Morgan et al., 2012; Takahashi et al., 2016). 
Infection with intestinal helminthes probably increases bacterially pro-
duced SCFAs concentrations, and, as a result, allergic airway inflam-
mation is attenuated in the host (Zaiss et al., 2015). On the other hand, 
the ability of SCFAs to promote host regulatory T-cell responses may 
contribute to limited immuno-pathology and promotes chronic parasite 
infection (Arpaia et al., 2013; Furusawa et al., 2013). However, we did 
not directly measure intestinal SCFAs levels. More studies are needed to 
dissect this effect of O. felineus infection. 
At the genus level, the abundance of Eubacterium eligens group was 
significant increased in the O. felineus-infected children. E. eligens is a 
pectin-degrading Firmicutes species that has the anti-inflammatory po-
tential by promoting the production of IL-10 by epithelial cells (Chung 
et al., 2017). Two taxa belonging to Bacteroidetes were significantly 
increased in O. felineus infected patients. Consistent with previous re-
ports, several Bacteroides species can produce enterotoxin previously 
associated with ulcerative colitis, stimulate interleukin-8 (IL-8) and 
tumor necrosis factor alpha (TNF-α) secretion in intestinal epithelial 
cells and intensify colitis symptoms in a murine model of ulcerative 
colitis (Ohkusa et al., 2009), while some strains of this genus have 
anti-inflammatory effects (Gauffin Cano et al., 2012; Hiippala et al., 
2020; Ihekweazu et al., 2019). In previous studies, the lower abundance 
of Bacteroides was observed in the C. sinensis infected patients (Xu et al., 
2018). Since changes were observed in populations of several bacteria 
with putative pro-/anti-inflammatory properties, whether the gut 
microbiota affected by the O. felineus infection could either contribute to 
or protect from inflammation is difficult to ascertain and, therefore, 
further analyses are required. 
We also evaluated the association between intensity of helminth 
infection and gut microbiota composition. Bifidobacteriaceae, including 
genus Bifidobacterium, and Akkermansia were negatively correlated with 
the number of O. felineus EPG of feces. Bifidobacterium is an important 
probiotic bacterium, considered as potentially anti-inflammatory taxa 
(Khokhlova et al., 2012). As it shown in a previous study, the abundance 
of this genus also has a negative correlation with EPG of feces in 
C. sinensis-infected individuals (Xu et al., 2018). Akkermansia is a 
mucin-degrading bacteria, reduction in their abundance has been 
associated with inflammation and alterations of metabolic processes 
(Verhoog et al., 2019). On the family level, Desulfovibrionaceae and 
Erysipelotrichaceae showed direct associations with infection intensity. 
These taxa were implicated in the development of obesity-related 
metabolic disorders (Zhang et al., 2010). Apparently, the gut micro-
biome signature of O. felineus combines features known to be both 
directly and inversely associated with different disorders highlighting 
the complex nature of the helminth’s interactions with the host and 
commensal microbiome. 
Our results show that deworming was not associated with changes in 
microbial alpha diversity, however, some significant differences were 
seen in the abundances of some microorganisms in the gut microbiota of 
the infected children before and after anthelmintic treatment. Specif-
ically, the abundance of bacteria belonging to the Enterobacteriaceae 
family, Escherichia, Lachnospira, Anaerosporobacter, Ruminiclostridium 6, 
and Blautia genera (altered by O. felineus infection) after treatment 
resembled the levels typical for the control group. Conversely, the 
disease-specific shifts for some taxa persisted as long as 3 months after 
treatment (Barnesiellaceae, Bacteroides). At the phylum level, prazi-
quantel treatment was associated with a decreased relative abundance 
of Synergistetes. This phylum is associated with periodontal diseases 
(Belibasakis et al., 2013; McCracken and Nathalia Garcia, 2020). In the 
other study, a higher proportion Synergistetes was evident in the group 
of participants infected with O. felineus in comparison with the 
Fig. 2. Beta-diversity analysis. 
Non-metric multidimensional scaling in Aitchison metric for gut microbiota of 
all study cohort. Each point represents a sample and points with the same color 
belong to the same group. 
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uninfected participants (Saltykova et al., 2016). We found a significant 
decrease in the proportion of bacteria Megasphaera, Roseburia, and 
Olsenella in praziquantel-treated patients compared to infected and 
control participants. It has been reported that patients with cirrhosis and 
primary biliary cholangitis have a higher level of Megasphaera compared 
to healthy controls (Chen et al., 2016; Lv et al., 2016). Olsenella also is 
positively associated with soil-transmitted helminths infections across 
Liberia and Indonesia (Rosa et al., 2018). We observed that abundance 
of Olsenella directly correlates with the O. felineus infection intensity. 
Species of Roseburia genus are known to be important 
butyrate-producing bacteria (Louis and Flint, 2009). The abundance of 
other butyrate-producing bacteria, namely Faecalibacterium, was 
increased in praziquantel-treated patients in comparison with infected 
or control participants. 
The data presented here have some limitations. In our study, par-
ticipants were examined one time posttreatment. The 3-month time 
point allowed us to examine the longer-term impact of helminth clear-
ance. This study was not aimed to estimate the data regarding the effect 
of short term removal of helminths on microbiota and the impact of 
praziquantel treatment on uninfected children. The V4 region of 16S 
rRNA was analyzed. Although sequencing a longer region would result 
in a more precise taxonomic classification of each read, the V4 format 
allows a more accurate estimate of the gut archaea levels than V3-4 (due 
to variability in amplicon length for these prokaryotes). Moreover, V4 
region is widely used in human gut microbiome surveys (Klimenko et al., 
2018; McDonald et al., 2018; Wei et al., 2020). As each gene region 
produces a certain bias, an alternative would be to use a mix of primers 
covering multiple gene regions (Barb et al., 2016; Tremblay et al., 2015). 
Table 2 
Significant differences in the abundances of gut bacteria (at several taxonomic levels) between comparison groups.  












uninfected vs after 
treatment 
O. felineus-infected vs 
after treatment 
Proteobacteria 71.64 (14.31) 257.19 (54.49) 96.67 (17.96) 2.58E- 
06 







0.004 0.017 0.009 0.969 0.018 
Synergistetes 0.37 (0.33) 0.59 (0.51) 0.01 (0.01) 0.014 0.041 0.916 0.039 0.012 
Enterobacteriaceae 31.63 (9.94) 150.61 (48.97) 21.03 (6.76) 1.11E- 
06 
2.51E-05 0.001 0.616 4.80E-06 
Atopobiaceae 12.44 (4.90) 6.69 (3.24) 0.57 (0.24) 1.23E- 
07 
5.53E-06 0.508 5.36E-07 0.0002 
Escherichia-Shigella 27.71 (9.21) 131.61 (45.48) 18.66 (6.21) 6.00E- 
06 
0.0004 0.002 0.662 1.92E-05 
Lachnospira 2.67 (0.78) 9.70 (2.83) 4.04 (1.27) 0.003 0.026 0.004 0.570 0.048 
Anaerosporobacter 0.18 (0.10) 1.50 (0.70) 0.02 (0.02) 0.0002 0.004 0.013 0.187 0.001 
Ruminiclostridium 6 1.72 (0.73) 6.24 (2.33) 1.69 (0.66) 0.006 0.035 0.022 0.999 0.017 
Eubacterium eligens group 3.42 (1.13) 13.00 (4.53) 5.63 (1.73) 0.007 0.035 0.006 0.476 0.117 
Faecalitalea 0.02 (0.02) 0.52 (0.29) 1.21 (0.66) 0.005 0.035 0.030 0.004 0.531 
Bacteroides 105.37 
(24.28) 
238.04 (50.03) 235.06 
(51.92) 
0.006 0.035 0.014 0.017 0.999 
Barnesiella 2.54 (0.81) 7.81 (2.80) 8.97 (3.19) 0.007 0.035 0.026 0.011 0.937 
Blautia 789.02 
(90.70) 
444.76 (50.65) 685.46 
(79.62) 
0.001 0.015 0.002 0.666 0.024 
Eubacterium hallii group 182.82 
(22.52) 
110.84 (13.55) 123.77 
(15.43) 
0.010 0.048 0.013 0.070 0.803 
Lachnospiraceae FCS020 
group 
13.90 (2.13) 6.96 (1.09) 10.02 (1.57) 0.007 0.035 0.005 0.296 0.229 
Sellimonas 1.49 (0.76) 1.08 (0.55) 19.40 (9.71) 5.03E- 
05 
0.001 0.895 0.001 0.0002 
Eisenbergiella 1.18 (0.58) 0.88 (0.43) 9.40 (4.51) 0.001 0.013 0.905 0.008 0.002 
Faecalibacterium 0.90 (0.32) 2.07 (0.61) 5.94 (1.79) 9.19E- 
06 
0.0004 0.124 3.47E-05 0.005 
Erysipelatoclostridium 1.13 (0.45) 1.10 (0.37) 3.40 (1.38) 0.010 0.046 0.998 0.033 0.024 
Varibaculum 0.02 (0.02) 0.18 (0.10) 2.48 (1.22) 1.80E- 
05 
0.001 0.194 0.0004 0.002 
Megasphaera 16.96 (11.86) 18.52 (12.82) 0.04 (0.04) 3.79E- 
07 
5.24E-05 0.996 6.78E-06 4.59E-06 
Roseburia 54.37 (9.86) 53.60 (9.38) 27.80 (4.97) 0.003 0.031 0.998 0.018 0.009 
Olsenella 3.51 (1.42) 2.26 (0.91) 0.25 (0.12) 9.30E- 
05 
0.002 0.722 0.0002 0.002 
Rikenellaceae RC9 gut 
group 
2.31 (1.36) 2.70 (1.57) 0.13 (0.09) 0.001 0.017 0.980 0.006 0.003 
Leuconostoc 0.12 (0.10) 0.52 (0.37) 4.60 (3.24) 0.003 0.026 0.374 0.003 0.079 
Flavonifractor 0.36 (0.16) 0.95 (0.33) 1.68 (0.57) 0.003 0.026 0.091 0.003 0.170 
Oscillibacter 0.99 (0.26) 2.19 (0.53) 3.05 (0.88) 0.005 0.035 0.050 0.005 0.554 
Howardella 3.39 (1.10) 1.14 (0.39) 0.79 (0.28) 0.006 0.035 0.055 0.008 0.738 
Ruminococcus gauvreauii 
group 
45.35 (9.55) 26.35 (5.86) 18.38 (4.13) 0.007 0.035 0.139 0.006 0.398 
Slackia 3.04 (0.87) 1.96 (0.57) 0.79 (0.25) 0.007 0.036 0.531 0.006 0.096 
Lachnospiraceae 
NK4A136 group 
11.35 (2.13) 18.14 (3.34) 6.23 (1.21) 0.0003 0.006 0.179 0.071 0.0003 
Lachnospiraceae ND3007 
group 
6.15 (1.53) 7.86 (1.97) 3.04 (0.93) 0.009 0.044 0.703 0.084 0.009 
Prevotella 2 2.14 (1.28) 11.62 (6.78) 0.75 (0.46) 0.005 0.035 0.109 0.441 0.004 
Tyzzerella 4 1.45 (0.74) 3.10 (1.54) 0.25 (0.14) 0.004 0.032 0.534 0.061 0.003 
SE, Standard Error. P < 0.05 indicates significant differen 
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5. Conclusion 
We obtained new data regarding the impact of O. felineus infection 
and praziquantel treatment on the intestinal microbiome, and some of 
these effects were associated with the infection intensity. These results 
could be used to the prevention, and treatment of O. felineus infection, 
and the potential development of new strategies for the control of 
chronic non-communicable diseases. This requires further studies. 
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Easton, A.V., Quiñones, M., Vujkovic-Cvijin, I., Oliveira, R.G., Kepha, S., Odiere, M.R., 
Anderson, R.M., Belkaid, Y., Nutman, T.B., 2019. The impact of anthelmintic 
treatment on human gut microbiota based on cross-sectional and pre- and 
postdeworming comparisons in Western Kenya. MBio 10. https://doi.org/10.1128/ 
mBio.00519-19. 
Efimova, D, Tyakht, A, Popenko, A, Vasilyev, A, Altukhov, I, Dovidchenko, N, 
Odintsova, V, Klimenko, N, Loshkarev, R, Pashkova, M, Elizarova, A, Voroshilova, V, 
Slavskii, S, Pekov, Y, Filippova, E, Shashkova, T, Levin, E, Alexeev, D, 2018. 
Knomics-Biota a system for exploratory analysis of human gut microbiota data. 
BioData Min 11 (25). https://doi.org/10.1186/s13040-018-0187-3. 
Elkins, D., Sithithaworn, P., Haswell-Elkins, M., Kaewkes, S., Wongratanacheewin, S., 
Awacharagan, P., 1991. Opisthorchis viverrini: relationships between egg counts, 
worms recovered and antibody levels within an endemic community in Northeast 
Thailand. Parasitology 102, 283–288. https://doi.org/10.1017/ 
S0031182000062600. 
Fadrosh, D.W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R.M., Ravel, J., 2014. 
An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on 
the Illumina MiSeq platform. Microbiome 2. https://doi.org/10.1186/2049-2618-2- 
6. 
Fedorova, O.S., Fedotova, M.M., Sokolova, T.S., Golovach, E.A., Kovshirina, Y.V., 
Ageeva, T.S., Kovshirina, A.E., Kobyakova, O.S., Ogorodova, L.M., Odermatt, P., 
2018. Opisthorchis felineus infection prevalence in Western Siberia: a review of 
Russian literature. Acta Trop. https://doi.org/10.1016/j.actatropica.2017.11.018. 
Fedorova, O.S., Janse, J.J., Ogorodova, L.M., Fedotova, M.M., Achterberg, R.A., 
Verweij, J.J., Fernández-Rivas, M., Versteeg, S.A., Potts, J., Minelli, C., van Ree, R., 
Burney, P., Yazdanbakhsh, M., 2017. Opisthorchis felineus negatively associates with 
skin test reactivity in Russia-EuroPrevall-International Cooperation study. Allergy 
72, 1096–1104. https://doi.org/10.1111/all.13120. 
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., 
Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., 
Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J. 
M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., 
Honda, K., Hase, K., Ohno, H., 2013. Commensal microbe-derived butyrate induces 
the differentiation of colonic regulatory T cells. Nature 504, 446–450. https://doi. 
org/10.1038/nature12721. 
T.S. Sokolova et al.                                                                                                                                                                                                                             
Acta Tropica 217 (2021) 105835
9
Gauffin Cano, P, Santacruz, A, Moya, A, Sanz, Y, 2012. Bacteroides uniformis CECT 7771 
ameliorates metabolic and immunological dysfunction in mice with high-fat-diet 
induced obesity. PLoS One 7. https://doi.org/10.1371/journal.pone.0041079. 
Gause, W.C., Maizels, R.M., 2016. Macrobiota - helminths as active participants and 
partners of the microbiota in host intestinal homeostasis. Curr. Opin. Microbiol. 
https://doi.org/10.1016/j.mib.2016.04.004. 
Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W.F., Veldhuyzen Van Zanten, S.J.O., 
2006. Differences between tissue-associated intestinal microfloras of patients with 
Crohn’s disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136–4141. https://doi. 
org/10.1128/JCM.01004-06. 
Gouveia, M.J., Pakharukova, M.Y., Laha, T., Sripa, B., Maksimova, G.A., Rinaldi, G., 
Brindley, P.J., Mordvinov, V.A., Amaro, T., Santos, L.L., da Costa, J.M.C., Vale, N., 
2017. Infection with Opisthorchis felineus induces intraepithelial neoplasia of the 
biliary tract in a rodent model. Carcinogenesis. https://doi.org/10.1093/carcin/ 
bgx042. 
Hiippala, K, Kainulainen, V, Suutarinen, M, Heini, T, Bowers R, J, Jasso-Selles, D, 
Lemmer, D, Valentine, M, Barnes, R, Engelthaler M, D, Satokari, R, 2020. Isolation of 
anti-inflammatory and epithelium reinforcing Bacteroides and Parabacteroides spp. 
from a healthy fecal donor. Nutrients 12. https://doi.org/10.3390/nu12040935. 
Hsieh, Y.-J., Fu, C.-L., Hsieh, M.H., 2014. Helminth-induced interleukin-4 abrogates 
invariant natural killer T cell activation-associated clearance of bacterial infection. 
Infect. Immun. 82, 2087–2097. https://doi.org/10.1128/IAI.01578-13. 
Ihekweazu D, F, Fofanova Y, T, Queliza, K, Nagy-Szakal, D, Stewart J, C, Engevik A, M, 
Hulten G, K, Tatevian, N, Graham Y, D, Versalovic, J, Petrosino F, J, Kellermayer, R, 
2019. Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal 
transplant and multi-strain bacteriotherapy in a murine colitis model. Gut Microbes 
10, 504–520. https://doi.org/10.1080/19490976.2018.1560753. 
Imhann, F., Vila, V., Bonder, A., Fu, M.J., Gevers, J., Visschedijk, D., Spekhorst, M.C., 
Alberts, L.M., Franke, R., van Dullemen, L., Ter Steege, H.M., Huttenhower, R.W.F., 
Dijkstra, C., Xavier, G., Festen, R.J., Wijmenga, E.A.M., Zhernakova, C., 
Weersma, A., R.K., 2018. Interplay of host genetics and gut microbiota underlying 
the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108–119. 
https://doi.org/10.1136/gutjnl-2016-312135. 
Itthitaetrakool, U., Pinlaor, P., Pinlaor, S., Chomvarin, C., Dangtakot, R., Chaidee, A., 
Wilailuckana, C., Sangka, A., Lulitanond, A., Yongvanit, P., 2016. Chronic 
Opisthorchis viverrini infection changes the liver microbiome and promotes 
helicobacter growth. PLoS One 11. https://doi.org/10.1371/journal.pone.0165798. 
Khokhlova, E.V., Smeianov, V.V., Efimov, B.A., Kafarskaia, L.I., Pavlova, S.I., 
Shkoporov, A.N., 2012. Anti-inflammatory properties of intestinal Bifidobacterium 
strains isolated from healthy infants. Microbiol. Immunol. 56, 27–39. https://doi. 
org/10.1111/j.1348-0421.2011.00398.x. 
Klimenko, N.S., Tyakht, A.V., Popenko, A.S., Vasiliev, A.S., Altukhov, I.A., Ischenko, D.S., 
Shashkova, T.I., Efimova, D.A., Nikogosov, D.A., Osipenko, D.A., Musienko, S.V, 
Selezneva, K.S., Baranova, A., Kurilshikov, A.M., Toshchakov, S.M., Korzhenkov, A. 
A., Samarov, N.I., Shevchenko, M.A., Tepliuk, A.V, Alexeev, D.G., 2018. Microbiome 
responses to an uncontrolled short-term diet intervention in the frame of the citizen 
science project. Nutrients 10. https://doi.org/10.3390/nu10050576. 
Kumari, R., Ahuja, V., Paul, J., 2013. Fluctuations in butyrate-producing bacteria in 
ulcerative colitis patients of North India. World J. Gastroenterol. 19, 3404–3414. 
https://doi.org/10.3748/wjg.v19.i22.3404. 
Kuznetsova, A., Brockhoff, P.B., Christensen, R.H.B., 2017. lmerTest package: tests in 
linear mixed effects models. J. Stat. Softw. 82 https://doi.org/10.18637/jss.v082. 
i13. 
Lai, C.K.W., Beasley, R., Crane, J., Foliaki, S., Shah, J., Weiland, S., Aït-Khaled, N., 
Anderson, H.R., Asher, M.I., Beasley, R., Björksten, B., Brunekreef, B., Crane, J., 
Ellwood, P., Flohr, C., Foliaki, S., Forastiere, F., García-Marcos, L., Keil, U., Lai, C.K. 
W., Mallol, J., Mitchell, E.A., Montefort, S., Odhiambo, J., Pearce, N., Robertson, C. 
F., Shah, J., Stewart, A.W., Strachan, D., Von Mutius, E., Weiland, S.K., 
Weinmayr, G., Williams, H., Wong, G., 2009. Global variation in the prevalence and 
severity of asthma symptoms: phase three of the International Study of Asthma and 
Allergies in Childhood (ISAAC). Thorax 64, 476–483. https://doi.org/10.1136/ 
thx.2008.106609. 
Lenth, R., 2019. emmeans: Estimated Marginal Means, aka Least-Squares Means. 
Liu, J., Wu, D., Ahmed, A., Li, X., Ma, Y., Tang, L., Mo, D., Ma, Y., Xin, Y., 2012. 
Comparison of the gut microbe profiles and numbers between patients with liver 
cirrhosis and healthy individuals. Curr. Microbiol. 65, 7–13. https://doi.org/ 
10.1007/s00284-012-0105-8. 
Louis, P., Flint, H.J., 2009. Diversity, Metabolism and Microbial Ecology of Butyrate- 
Producing Bacteria from the Human Large Intestine. https://doi.org/10.1111/ 
j.1574-6968.2009.01514.x. 
Lu, H., Wu, Z., Xu, W., Yang, J., Chen, Y., Li, L., 2011. Intestinal microbiota was assessed 
in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV 
cirrhotic patients. Microb. Ecol. 61, 693–703. https://doi.org/10.1007/s00248-010- 
9801-8. 
Lv, L.X., Fang, D.Q., Shi, D., Chen, D.Y., Yan, R., Zhu, Y.X., Chen, Y.F., Shao, L., Guo, F.F., 
Wu, W.R., Li, A., Shi, H.Y., Jiang, X.W., Jiang, H.Y., Xiao, Y.H., Zheng, S.S., Li, L.J., 
2016. Alterations and correlations of the gut microbiome, metabolism and immunity 
in patients with primary biliary cirrhosis. Environ. Microbiol. 18, 2272–2286. 
https://doi.org/10.1111/1462-2920.13401. 
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., 
Claes, K., Van Immerseel, F., Verbeke, K., Ferrante, M., Verhaegen, J., Rutgeerts, P., 
Vermeire, S., 2014. A decrease of the butyrate-producing species Roseburia hominis 
and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. 
Gut 63, 1275–1283. https://doi.org/10.1136/gutjnl-2013-304833. 
Maizels, R.M., McSorley, H.J., 2016. Regulation of the host immune system by helminth 
parasites. J. Allergy Clin. Immunol. 138, 666–675. https://doi.org/10.1016/j. 
jaci.2016.07.007. 
Maizels, R.M., Smits, H.H., McSorley, H.J., 2018. Modulation of host immunity by 
Helminths: the expanding repertoire of parasite effector molecules. Immunity 49, 
801–818. https://doi.org/10.1016/j.immuni.2018.10.016. 
Martino, C., Morton, J.T., Marotz, C.A., Thompson, L.R., Tripathi, A., Knight, R., 
Zengler, K., 2019. A novel sparse compositional technique reveals microbial 
perturbations. mSystems 4. https://doi.org/10.1128/msystems.00016-19. 
McCracken, B.A., Nathalia Garcia,, M., 2020. Phylum Synergistetes in the oral cavity: a 
possible contributor to periodontal disease. Anaerobe. https://doi.org/10.1016/j. 
anaerobe.2020.102250. 
McDonald, D., Hyde, E., Debelius, J.W., Morton, J.T., Gonzalez, A., Ackermann, G., 
Aksenov, A.A., Behsaz, B., Brennan, C., Chen, Y., De Right Goldasich, L., 
Dorrestein, P.C., Dunn, R.R., Fahimipour, A.K., Gaffney, J., Gilbert, J.A., Gogul, G., 
Green, J.L., Hugenholtz, P., Humphrey, G., Huttenhower, C., Jackson, M.A., 
Janssen, S., Jeste, D.V., Jiang, L., Kelley, S.T., Knights, D., Kosciolek, T., Ladau, J., 
Leach, J., Marotz, C., Meleshko, D., Melnik, A.V., Metcalf, J.L., Mohimani, H., 
Montassier, E., Navas-Molina, J., Nguyen, T.T., Peddada, S., Pevzner, P., Pollard, K. 
S., Rahnavard, G., Robbins-Pianka, A., Sangwan, N., Shorenstein, J., Smarr, L., 
Song, S.J., Spector, T., Swafford, A.D., Thackray, V.G., Thompson, L.R., Tripathi, A., 
Vázquez-Baeza, Y., Vrbanac, A., Wischmeyer, P., Wolfe, E., Zhu, Q., Knight, R., 
Mann, A.E., Amir, A., Frazier, A., Martino, C., Lebrilla, C., Lozupone, C., Lewis, C.M., 
Raison, C., Zhang, C., Lauber, C.L., Warinner, C., Lowry, C.A., Callewaert, C., 
Bloss, C., Willner, D., Galzerani, D.D., Gonzalez, D.J., Mills, D.A., Chopra, D., 
Gevers, D., Berg-Lyons, D., Sears, D.D., Wendel, D., Lovelace, E., Pierce, E., 
TerAvest, E., Bolyen, E., Bushman, F.D., Wu, G.D., Church, G.M., Saxe, G., 
Holscher, H.D., Ugrina, I., German, J.B., Caporaso, J.G., Wozniak, J.M., Kerr, J., 
Ravel, J., Lewis, J.D., Suchodolski, J.S., Jansson, J.K., Hampton-Marcell, J.T., 
Bobe, J., Raes, J., Chase, J.H., Eisen, J.A., Monk, J., Clemente, J.C., Petrosino, J., 
Goodrich, J., Gauglitz, J., Jacobs, J., Zengler, K., Swanson, K.S., Lewis, K., Mayer, K., 
Bittinger, K., Dillon, L., Zaramela, L.S., Schriml, L.M., Dominguez-Bello, M.G., 
Jankowska, M.M., Blaser, M., Pirrung, M., Minson, M., Kurisu, M., Ajami, N., 
Gottel, N.R., Chia, N., Fierer, N., White, O., Cani, P.D., Gajer, P., Strandwitz, P., 
Kashyap, P., Dutton, R., Park, R.S., Xavier, R.J., Mills, R.H., Krajmalnik-Brown, R., 
Ley, R., Owens, S.M., Klemmer, S., Matamoros, S., Mirarab, S., Moorman, S., 
Holmes, S., Schwartz, T., Eshoo-Anton, T.W., Vigers, T., Pandey, V., Treuren, W.V., 
Fang, X., Xu, Z., Jarmusch, Z., Geier, A., Reeve, J., Silva, N., Kopylova, R., 
Nguyen, E., Sanders, D., Salido Benitez, K., Heale, R.A., Abramson, A.C., 
Waldispühl, M., Butyaev, J., Drogaris, A., Nazarova, C., Ball, E., Gunderson, M., B., 
2018. American gut: an open platform for citizen science microbiome research. 
mSystems 3. https://doi.org/10.1128/msystems.00031-18. 
McMurdie, P.J., Holmes, S., 2013. Phyloseq: an R package for reproducible interactive 
analysis and graphics of microbiome census data. PLoS One 8. https://doi.org/ 
10.1371/journal.pone.0061217. 
Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., 
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